ADRB2 rs1800888: What Your Genotype Means

What each genotype means

Understanding the rs1800888 Variant

The rs1800888 variant is a single nucleotide polymorphism (SNP) found in the ADRB2 gene, which is located on chromosome 5. In scientific literature, this variant is often referred to as Thr164Ile, indicating that it causes a change in the amino acid sequence of the resulting protein. Specifically, it involves a substitution where the amino acid threonine is replaced by isoleucine at position 164. This position is located within a helical transmembrane domain of the receptor, a region that is highly conserved across the protein superfamily. Because of its location, this change is thought to have a significant impact on the receptor's structure and function. Unlike more common variants in the same gene, rs1800888 is considered a rare variant, meaning it is found at a much lower frequency in the general population.

The Role of the ADRB2 Gene

The ADRB2 gene encodes the beta-2 adrenergic receptor, a G protein-coupled receptor found on the surface of many cell types, including those in the smooth muscles of the airways. When activated by signaling molecules like epinephrine or norepinephrine, these receptors trigger a cascade of events that lead to muscle relaxation and bronchodilation—the widening of the airways. This mechanism is the primary target for many common asthma medications, known as beta-2 agonists, which are designed to mimic these natural signals to relieve symptoms. Because the ADRB2 protein is essential for this physiological response, variations in the gene sequence can theoretically alter how well the receptor functions or how sensitive it is to both natural signals and therapeutic drugs. Understanding these variations is a key focus of pharmacogenomics, the study of how genes affect an individual's response to medications.

Research and Clinical Associations

Research into rs1800888 has primarily focused on its functional consequences and its potential impact on drug response. Studies have suggested that this variant may be associated with a reduced sensitivity to beta-2-receptor agonists, potentially resulting in decreased bronchodilation or altered vasodilation. While some research has linked the variant to adverse events during long-acting beta-agonist (LABA) therapy, the evidence remains moderate and sometimes conflicting. It is important to note that while some studies have observed associations between this variant and clinical outcomes, other research has found no significant link, or has highlighted that the effects may be highly dependent on the specific population studied. Because of this heterogeneity in findings, the clinical utility of testing for this specific variant is still a subject of ongoing investigation rather than a standard diagnostic practice.

What This Information Means for You

If you have received information about your rs1800888 genotype, it is important to interpret it within the context of current scientific understanding. Genetic variants are only one of many factors—including environment, lifestyle, and other genetic markers—that influence how your body responds to medications. The presence of a specific genotype does not guarantee a particular clinical outcome, nor does it serve as a medical diagnosis. If you are concerned about how your genetics might influence your response to asthma treatments or other medications, you should discuss this with your healthcare provider or a clinical pharmacist. They can help you understand the relevance of your genetic profile in the context of your overall health and current treatment plan. Never make changes to your prescribed medication regimen based on genetic test results without consulting a qualified medical professional.

Frequently asked questions

Sources & further reading

Related variants in ADRB2